Drugs / FP-01.1-Adjuvant
last change Apr 2013 re-read 3 minutes ago

FP-01.1-Adjuvant

Vaccine

Developed for
influenza

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy2 trials
Phase 1 NCT01701752 Comparator Sep 2012 → Apr 2013 influenza Immune Targeting Systems Ltd Completed No outcome recorded
Phase 1 NCT01677676 Comparator Jan → May 2012 influenza Immune Targeting Systems Ltd Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as FP-01.1-Adjuvant ClinicalTrials.gov intervention name — accepted as the source's own label NCT01677676 ↗
1

NCT01701752 ↗

Modality Vaccine “Influenza A Vaccine” NCT01677676 ↗
Route Intramuscular “IM injection” NCT01677676 ↗